Since its introduction to the market in 2012, Unyvero has been brought into numerous hospital laboratories and intensive care units throughout Europe. Leading clinical experts have tested the system and now appreciate the advantages of the Unyvero Solution in everyday clinical use.
Curetis to Present at Key Investor and Scientific Conferences in the Fourth Quarter 2017
MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics
European Meeting on Molecular Diagnostics - Noordwijk, Netherlands - October 11 to 13, 2017
CRIOAC, 3ème Congrès des Centres de Référence des Infections Ostéo-Articulaires Complexes - Tours, France - October, 19 to 20, 2017